Cannara Biotech Inc. (LOVE.V)
CAD 1.42
(-1.39%)
CAD 1.42
(-1.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 27.23 Million CAD | 57.12% |
| 2022 | 17.33 Million CAD | 68.32% |
| 2021 | 10.29 Million CAD | 740.93% |
| 2020 | 1.22 Million CAD | -27.68% |
| 2019 | 1.69 Million CAD | 964.45% |
| 2018 | 159.05 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.14 Million CAD | -49.72% |
| 2024 Q1 | 8.23 Million CAD | -16.79% |
| 2024 Q3 | 370.6 Thousand CAD | 68.05% |
| 2023 Q4 | 9.89 Million CAD | 16.47% |
| 2023 Q1 | 4.83 Million CAD | -30.44% |
| 2023 FY | 27.23 Million CAD | 57.12% |
| 2023 Q2 | 4.26 Million CAD | -11.81% |
| 2023 Q3 | 8.49 Million CAD | 99.39% |
| 2022 FY | 17.33 Million CAD | 68.32% |
| 2022 Q4 | 6.94 Million CAD | 46.29% |
| 2022 Q3 | 4.74 Million CAD | 57.47% |
| 2022 Q2 | 3.01 Million CAD | 1028.01% |
| 2022 Q1 | -324.95 Thousand CAD | -107.59% |
| 2021 Q2 | 2.09 Million CAD | 93.46% |
| 2021 Q1 | 1.08 Million CAD | 334.85% |
| 2021 Q3 | 4.41 Million CAD | 110.92% |
| 2021 Q4 | 4.27 Million CAD | -3.16% |
| 2021 FY | 10.29 Million CAD | 740.93% |
| 2020 FY | 1.22 Million CAD | -27.68% |
| 2020 Q4 | -461.15 Thousand CAD | -164.43% |
| 2020 Q3 | 715.74 Thousand CAD | 52.24% |
| 2020 Q2 | 470.13 Thousand CAD | -5.92% |
| 2020 Q1 | 499.69 Thousand CAD | -1.04% |
| 2019 Q2 | 436.6 Thousand CAD | -6.29% |
| 2019 Q3 | 285.62 Thousand CAD | -34.58% |
| 2019 Q4 | 504.94 Thousand CAD | 76.78% |
| 2019 FY | 1.69 Million CAD | 964.45% |
| 2019 Q1 | 465.9 Thousand CAD | 0.0% |
| 2018 FY | 159.05 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5499.00 CAD | -495094.126% |
| CanadaBis Capital Inc. | 11.78 Million CAD | -131.088% |
| Decibel Cannabis Company Inc. | 41.85 Million CAD | 34.947% |
| Delivra Health Brands Inc. | 6.39 Million CAD | -325.547% |
| Entourage Health Corp. | 3.7 Million CAD | -634.438% |
| Lifeist Wellness Inc. | 5.34 Million CAD | -409.53% |
| Medicure Inc. | 13.98 Million CAD | -94.658% |
| PharmaCielo Ltd. | -1.36 Million CAD | 2089.333% |
| Rubicon Organics Inc. | 13.14 Million CAD | -107.223% |
| BioSyent Inc. | 25.14 Million CAD | -8.305% |
| Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 1246357.437% |